Brown Advisory Securities’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-540
| Closed | -$245K | – | 19 |
|
|
2022
Q3 | $245K | Sell |
540
-292
| -35% | -$140K | 0.9% | 37 |
|
|
2022
Q2 | $401K | Sell |
832
-68
| -8% | -$33.6K | 0.38% | 73 |
|
|
2022
Q1 | $443K | Sell |
900
-788
| -47% | -$360K | 0.26% | 93 |
|
|
2021
Q4 | $782K | Sell |
1,688
-243
| -13% | -$102K | 0.33% | 76 |
|
|
2021
Q3 | $723K | Sell |
1,931
-91
| -5% | -$34.6K | 0.21% | 102 |
|
|
2021
Q2 | $772K | Hold |
2,022
| – | – | 0.12% | 113 |
|
|
2021
Q1 | $726K | Sell |
2,022
-15
| -0.7% | -$4.82K | 0.12% | 113 |
|
|
2020
Q4 | $654K | Buy |
2,037
+750
| +58% | +$230K | 0.11% | 120 |
|
|
2020
Q3 | $346K | Hold |
1,287
| – | – | 0.07% | 168 |
|
|
2020
Q2 | $340K | Hold |
1,287
| – | – | 0.07% | 165 |
|
|
2020
Q1 | $290K | Sell |
1,287
-150
| -10% | -$40.9K | 0.07% | 170 |
|
|
2019
Q4 | $435K | Sell |
1,437
-24
| -2% | -$6.6K | 0.1% | 153 |
|
|
2019
Q3 | $351K | Sell |
1,461
-860
| -37% | -$236K | 0.1% | 167 |
|
|
2019
Q2 | $655K | Sell |
2,321
-346
| -13% | -$94.5K | 0.17% | 120 |
|
|
2019
Q1 | $765K | Sell |
2,667
-400
| -13% | -$116K | 0.18% | 113 |
|
|
2018
Q4 | $783K | Buy |
3,067
+73
| +2% | +$20.1K | 0.15% | 134 |
|
|
2018
Q3 | $820K | Sell |
2,994
-9
| -0.3% | -$2.34K | 0.13% | 156 |
|
|
2018
Q2 | $715K | Hold |
3,003
| – | – | 0.12% | 171 |
|
|
2018
Q1 | $660K | Buy |
3,003
+1
| +0% | +$235 | 0.12% | 167 |
|
|
2017
Q4 | $676K | Buy |
3,002
+96
| +3% | +$20.4K | 0.13% | 162 |
|
|
2017
Q3 | $550K | Buy |
2,906
+400
| +16% | +$76.1K | 0.12% | 175 |
|
|
2017
Q2 | $471K | Buy |
2,506
+1,137
| +83% | +$204K | 0.11% | 192 |
|
|
2017
Q1 | $226K | Sell |
1,369
-106
| -7% | -$16.9K | 0.06% | 283 |
|
|
2016
Q4 | $211K | Buy |
+1,475
| New | +$198K | 0.06% | 280 |
|
|
2016
Q2 | – | Sell |
-1,527
| Closed | -$211K | – | 310 |
|
|
2016
Q1 | $211K | Buy |
1,527
+3
| +0.2% | +$401 | 0.07% | 238 |
|
|
2015
Q4 | $212K | Buy |
1,524
+9
| +0.6% | +$1.24K | 0.07% | 237 |
|
|
2015
Q3 | $213K | Buy |
1,515
+153
| +11% | +$23K | 0.08% | 249 |
|
|
2015
Q2 | $224K | Sell |
1,362
-6
| -0.4% | -$959 | 0.07% | 263 |
|
|
2015
Q1 | $211K | Buy |
+1,368
| New | +$195K | 0.07% | 262 |
|
|
2014
Q3 | – | Sell |
-1,851
| Closed | -$200K | – | 308 |
|
|
2014
Q2 | $200K | Buy |
+1,851
| New | +$191K | 0.07% | 261 |
|
Other funds holding ELV
Brown Advisory Securities's ELV Position: Q4 2022 in Review
Brown Advisory Securities sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 540 shares — an estimated $245K sold.
Brown Advisory Securities first reported a position in ELV in Q2 2014 and held it in 30 quarters. The position peaked at $820K in Q3 2018. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.
- Brown Advisory Securities reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
- Brown Advisory Securities sold 540 Elevance Health shares in Q4 2022, an estimated $245K.
- Brown Advisory Securities first reported a position in Elevance Health in Q2 2014 and held it in 30 quarters.
- Brown Advisory Securities's Elevance Health position peaked at $820K in Q3 2018.
- 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.
Based on Brown Advisory Securities's 13F filing for Q4 2022.